$4 Billion Global Influenza Vaccines Market & Forecast to 2022

Views:
 
Category: Entertainment
     
 

Presentation Description

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022. For Sample Pages of the Report: http://www.dpiresearch.com/page_info.php?P_ID=50 Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants. The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second-largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

Comments

Presentation Transcript

Slide1:

www.dpiresearch.com

Slide2:

www.dpiresearch.com Publish Date : November 2016 No. of Pages : 205 Geography Coverage : Seven Countries Price for Single User Licence : USD 2000 Price for Global User Licence : USD 2500 Delivery Time : Within 24 hours Seasonal Influenza Vaccine Market

Slide3:

www.dpiresearch.com Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. Seasonal Influenza Vaccine Market

Slide4:

www.dpiresearch.com Report Coverage: Executive Summary Seasonal Influenza Vaccine Market in Top Seven Countries – Market Overview Seasonal Influenza Vaccine Market Drivers and Barriers Seasonal Influenza Vaccine Market in Top Seven Countries – Geographical Landscape Seasonal Influenza Vaccine Production & Distribution in United States Seasonal Influenza Vaccine Market

Slide5:

www.dpiresearch.com Report Coverage Continues: 6. Seasonal Influenza Vaccine Market – Regulatory Landscape 7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations 8. Seasonal Influenza Vaccine – Pipeline Assessment 9. Seasonal Influenza Vaccine – Clinical Trials Assessment by Phase and Trial Status 10. Key Companies Analysis Seasonal Influenza Vaccine Market

Slide6:

www.dpiresearch.com Contact us: sales@dpiresearch.com Seasonal Influenza Vaccine Market For More Details visit: www.dpiresearch.com

authorStream Live Help